Detalhe da pesquisa
1.
PCIG: a web-based application to explore immune-genomics interactions across cancer types.
Bioinformatics
; 38(8): 2374-2376, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179562
2.
CXCR2 inhibition enables NASH-HCC immunotherapy.
Gut
; 2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477863
3.
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
J Hepatol
; 73(2): 315-327, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173382
4.
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.
Br J Cancer
; 121(4): 340-343, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285588
5.
Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma.
Clin Cancer Res
; 28(11): 2449-2460, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302601
6.
Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.
Clin Cancer Res
; 28(20): 4509-4520, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998012
7.
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.
Clin Cancer Res
; 26(23): 6350-6361, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873569
8.
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Elife
; 92020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31939734